Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Published by: University of California, Berkeley
Published in: "California Management Review", 2004

Abstract

The need to play catch-up in biotechnology has led Germany and Japan to adopt novel technology policies. Whereas policies to assist domestic industries have traditionally been geared toward incumbent firms, current trends revolve around ''science entrepreneurship'' - reforms in the national R&D (research and development) system and targeted incentives for biotechnology scientists to file patents and start up their own firms. Japan, in particular, has recognized that catching up with the United States in basic science and in the commercialization of scientific research represents a kind of final frontier.

About

Abstract

The need to play catch-up in biotechnology has led Germany and Japan to adopt novel technology policies. Whereas policies to assist domestic industries have traditionally been geared toward incumbent firms, current trends revolve around ''science entrepreneurship'' - reforms in the national R&D (research and development) system and targeted incentives for biotechnology scientists to file patents and start up their own firms. Japan, in particular, has recognized that catching up with the United States in basic science and in the commercialization of scientific research represents a kind of final frontier.

Related